Zu unserem Team

Dr. Florian von Alten

Geschäftsführender Partner

Florian is a managing partner at Oaklins Germany and served as president and chairman of Oaklins International between 2016 and 2019. He joined the firm as an M&A consultant in 1994 and became a partner in 1998. During the last 29 years at Oaklins, Florian has closed over 130 M&A transactions, many of them cross-border, mainly in the industrial space. Most of his clients are privately-owned Middelstand companies, but also include larger conglomerates and private equity firms. He has particular expertise in industrial manufacturing, machinery, engineering, industrial automation, precision metal processing, tool manufacturing, injection molding, electronics, food & beverage and construction and facility management. Florian leads the industrial machinery & components team and is an active member of the food & beverage team. Notable clients he has recently advised include Lisega SE, Swiss Steel, SLF Spindel- und Lagerungstechnik Fraureuth, Hawita, AWAX, Mabanaft and Vebego. He also has close contacts with private equity companies, such as Avedon, Afinum, Auctus, Bregal, Deutsche Beteiligungs AG, GIMV, H.I.G., IK Partners, NORD Holding, Paragon, Triton, VR Equity Partner and VTC.

Prior to 1994, Florian worked at Siemens Components Pte Ltd. in Singapore. He has a doctorate in economics and political economy and studied business administration at the universities of Goettingen, Germany, and Fribourg, Switzerland.

Dr. Florian  von Alten
Standort
Hamburg, Deutschland

E-Mail


Telefon
+49 40 34914168

123.tv has been acquired by DVC Partners
Private Equity | Technologie, Medien und Telekommunikation

123.tv has been acquired by DVC Partners

Weitere Informationen
GCT GmbH has been acquired by CTC India and JoReiCo GmbH
Maschinen- & Anlagenbau, Komponenten

GCT GmbH has been acquired by CTC India and JoReiCo GmbH

Weitere Informationen
bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG
Gesundheitswesen

bioXXmed AG has sold Rancoderm GmbH to Rose Investment- und Beteiligungs AG

Weitere Informationen